Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda M S Resar

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Cancer Research|January 14, 2010
The high mobility group A1 gene: transforming inflammatory signals into cancer?Linda M S Resar
Expert Opinion on Therapeutic Targets|April 2, 2014
The high mobility group A1 molecular switch: turning on cancer - can we turn it off?Tait H Huso, Linda M S Resar
Expert Review of Anticancer Therapy|January 14, 2014
Hitting the bull's eye: targeting HMGA1 in cancer stem cellsBreann L Yanagisawa, Linda M S Resar
Cell Research|June 15, 2011
AKNA: another AT-hook transcription factor "hooking-up" with inflammationAlison R Moliterno, Linda M S Resar
Hematology. American Society of Hematology. Education Program|February 20, 2015
Bloodless medicine: what to do when you can't transfuseLinda M S Resar, Steven M Frank
Histology and Histopathology|March 16, 2012
High mobility group A1 and cancer: potential biomarker and therapeutic targetSandeep N Shah, Linda M S Resar
International Journal of Molecular Sciences|March 13, 2025
High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN ProgressionLinda M S Resar, Li Z Luo
Anesthesia and Analgesia|January 13, 2023
In ResponseSteven M Frank, Shruti Chaturvedi, Linda M S Resar
Cell Cycle (Georgetown, Tex.)|December 16, 2016
Hmga1 deficiency: "SAC-King" the SAC genes to incite chromosomal instabilityLingling Xian, Karen A Reddy, Linda M S Resar
Pediatric Blood & Cancer|January 27, 2007
Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemiaPatrick Hines, George J Dover, Linda M S Resar
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Cancer Research|January 14, 2010
The high mobility group A1 gene: transforming inflammatory signals into cancer?Linda M S Resar
Expert Opinion on Therapeutic Targets|April 2, 2014
The high mobility group A1 molecular switch: turning on cancer - can we turn it off?Tait H Huso, Linda M S Resar
Expert Review of Anticancer Therapy|January 14, 2014
Hitting the bull's eye: targeting HMGA1 in cancer stem cellsBreann L Yanagisawa, Linda M S Resar
Cell Research|June 15, 2011
AKNA: another AT-hook transcription factor "hooking-up" with inflammationAlison R Moliterno, Linda M S Resar
Hematology. American Society of Hematology. Education Program|February 20, 2015
Bloodless medicine: what to do when you can't transfuseLinda M S Resar, Steven M Frank
Histology and Histopathology|March 16, 2012
High mobility group A1 and cancer: potential biomarker and therapeutic targetSandeep N Shah, Linda M S Resar
International Journal of Molecular Sciences|March 13, 2025
High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN ProgressionLinda M S Resar, Li Z Luo
Anesthesia and Analgesia|January 13, 2023
In ResponseSteven M Frank, Shruti Chaturvedi, Linda M S Resar
Cell Cycle (Georgetown, Tex.)|December 16, 2016
Hmga1 deficiency: "SAC-King" the SAC genes to incite chromosomal instabilityLingling Xian, Karen A Reddy, Linda M S Resar
Pediatric Blood & Cancer|January 27, 2007
Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemiaPatrick Hines, George J Dover, Linda M S Resar
Pageof 8